Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 171 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location NCT ID

Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease

 		Steroid-refractory Acute Graft Versus Host Disease Phase4 China NCT06462469

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

 		Breast Cancer Phase1, Phase2 Australia
Canada
China
France
Germany
Italy
Netherlands
Portugal
Singapore
South Korea
Spain
United Kingdom
United States
View all
 NCT06247995

A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

 		Aortic Stenosis Phase2 Austria
Belgium
Canada
Czechia
Denmark
France
Germany
Israel
Italy
Netherlands
Portugal
Spain
Switzerland
United Kingdom
United States
View all
 NCT05646381

Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Prostate Cancer

 		Metastatic Castration Resistant Prostate Cancer Germany NCT06517719

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

 		C3G Phase3 Brazil
Canada
China
Germany
United States
View all
 NCT04817618

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis

 		Multiple Sclerosis Germany NCT06551519

A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®

 		Asthma South Korea NCT05217810

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

 		Oligometastatic Prostate Cancer (OMPC) Phase3 Argentina
Australia
Austria
Belgium
Brazil
Canada
China
Czechia
France
Germany
Greece
Hungary
Israel
Italy
Japan
Malaysia
Mexico
Netherlands
Puerto Rico
Singapore
Slovakia
Spain
Switzerland
Taiwan
United Kingdom
United States
View all
 NCT05939414

Dabrafenib and/or Trametinib Rollover Study

 		Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers, High Grade Glioma Phase4 Spain
United States 		NCT03340506

A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

 		Sickle Cell Disease Phase1, Phase2 United States NCT06546670